Ashton Thomas Securities’s Thermo Fisher Scientific TMO Stock Holding History

Ashton Thomas Securities’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.05M	Sell	1,550 -2,574	-62%	-$1.53M	0.11%	166
2026 Q2	$2.06M	Sell	4,124 -1,656	-29%	-$795K	0.3%	73
2026 Q1	$2.84M	Sell	5,780 -175	-3%	-$95K	0.36%	68
2025 Q4	$3.46M	Buy	5,955 +334	+6%	+$189K	0.66%	35
2025 Q3	$2.73M	Buy	5,621 +3,722	+196%	+$1.73M	0.38%	63
2025 Q2	$770K	Buy	1,899 +23	+1%	+$9.6K	0.19%	130
2025 Q1	$939K	Buy	1,876 +30	+2%	+$16.2K	0.26%	101
2024 Q4	$966K	Buy	1,846 +29	+2%	+$15.9K	0.27%	92
2024 Q3	$1.12M	Buy	1,817 +862	+90%	+$510K	0.22%	102
2024 Q2	$508K	Buy	+955	New	+$547K	0.12%	160

Other funds holding TMO

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Ashton Thomas Securities's TMO Position: Q3 2026 in Review

Ashton Thomas Securities reduced its Thermo Fisher Scientific (TMO) stake by 62% in Q3 2026, selling an estimated $1.53M and leaving 1,550 shares worth $1.05M. The position accounts for 0.11% of the portfolio, ranked #166.

Ashton Thomas Securities first reported a position in TMO in Q2 2024 and has held it in 10 quarters since. The position peaked at $3.46M in Q4 2025. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Ashton Thomas Securities held 1,550 shares of Thermo Fisher Scientific worth $1.05M as of Q3 2026.
Ashton Thomas Securities sold 2,574 Thermo Fisher Scientific shares in Q3 2026, an estimated $1.53M.
Thermo Fisher Scientific made up 0.11% of Ashton Thomas Securities's portfolio in Q3 2026, its #166 holding.
Ashton Thomas Securities first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 10 quarters since.
Ashton Thomas Securities's Thermo Fisher Scientific position peaked at $3.46M in Q4 2025.
2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Ashton Thomas Securities's 13F filing for Q3 2026, filed 26 Oct 2026.